PRP clinic Queen Creek: could a blood-based shot fit your joint?

Why does the same joint keep hurting?

Arthritis often leaves a joint stiff after sitting and sore after use. Past damage might change the way you walk, reach, or lift.

A tendon won't always settle when the same motion is repeated too often. The useful detail isn't a rating; it's whether stairs, reaching, walking, or lifting starts the soreness.

What can you try at home?

Ease back on the motion that starts the ache, but don't stop moving for days. Shorter walks, light strength work, and breaks during hard chores may help.

Heat or ice won't suit everyone, so use the one that feels good on your joint. Before taking pain medicine, ask whether it fits your health and other pills.

What does QC Kinetix offer for soreness?

At QC Kinetix, you may discuss regenerative treatments, meaning non-surgical care such as the blood-based PRP shot after a clinician examines your sore joint. The blood draw and the shot both happen in the clinic.

Here is the honest part: PRP won't help every person or every joint. Ask what the clinician found and why this shot might fit your soreness.

When does the joint need an exam?

Arrange an exam if the ache wakes you or limits walking and daily chores. Tell the clinician when it started, which motion hurts, and what you've tried.

You can't put off care when fever comes with a hot, puffy joint or spreading redness. Sudden weakness, a changed joint shape, or being unable to stand on the leg can't wait.

Sources

1. The 2019 ACR/Arthritis Foundation osteoarthritis guideline makes STRONG recommendations for exercise, weight loss in people with overweight or obesity, self-management programmes, tai chi, cane use, tibiofemoral bracing, topical and oral NSAIDs and intra-articular glucocorticoid injections for knee OA. Its conditional recommendations cover balance exercises, yoga, CBT, acupuncture, thermal modalities, radiofrequency ablation, acetaminophen, duloxetine and tramadol. Anything offered before a course of the strongly recommended options is being offered out of order.

   Kolasinski SL, Neogi T, Hochberg MC, et al. — 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis & Rheumatology, 2020. DOI: 10.1002/art.41142.

2. The OARSI non-surgical management guideline places intra-articular corticosteroids, intra-articular hyaluronic acid and aquatic exercise at Level 1B/Level 2 for KNEE osteoarthritis depending on comorbidity status, and specifically does NOT recommend them for hip or polyarticular osteoarthritis. Oral and transdermal opioids are strongly not recommended and acetaminophen is conditionally not recommended.

   Bannuru RR, Osani MC, Vaysbrot EE, et al. — OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis and Cartilage, 2019. DOI: 10.1016/j.joca.2019.06.011.

3. The ESSKA-ICRS consensus applied the RAND/UCLA appropriateness method to 216 clinical scenarios for intra-articular PRP in knee OA. Only 84 scenarios (38.9%) were rated appropriate, 9 (4.2%) inappropriate and 123 (56.9%) uncertain. PRP was judged appropriate in patients aged 80 or under with KL grade 0-III osteoarthritis AFTER failed conservative non-injective or injective treatment; it was NOT considered appropriate as a first treatment, nor in KL grade IV (bone-on-bone) osteoarthritis, where 91.7% and 87.5% of scenarios respectively were uncertain.

   Kon E, de Girolamo L, Laver L, et al. — Platelet-rich plasma injections for the management of knee osteoarthritis: The ESSKA-ICRS consensus. Recommendations using the RAND/UCLA appropriateness method for different clinical scenarios. Knee Surgery, Sports Traumatology, Arthroscopy, 2024. DOI: 10.1002/ksa.12320.

4. In the RESTORE trial - the largest placebo-controlled PRP trial in knee osteoarthritis - 288 adults aged 50+ with symptomatic Kellgren-Lawrence grade 2-3 medial knee OA received three weekly intra-articular injections of leukocyte-poor PRP from a commercial system or saline placebo. At 12 months the mean change in knee pain was -2.1 points with PRP versus -1.8 with saline (difference -0.4; 95% CI -0.9 to 0.2; P=.17) against a minimum clinically important difference of 1.8, and the change in medial tibial cartilage volume was -1.4% versus -1.2% (difference -0.2%; 95% CI -1.9% to 1.5%; P=.81). Twenty-nine of 31 prespecified secondary outcomes showed no significant between-group difference. The authors concluded the findings do not support use of PRP for knee OA.

   Bennell KL, Paterson KL, Metcalf BR, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial. JAMA, 2021. DOI: 10.1001/jama.2021.19415.

5. The Cochrane review of exercise for knee osteoarthritis found low- to moderate-certainty evidence that exercise probably improves pain, physical function and quality of life in the short term - but when the results were compared against established minimal important difference thresholds (12 points for pain, 13 for function, 15 for quality of life on 0-100 scales), the confidence intervals either did not reach those thresholds or spanned both important and unimportant improvement. Honest copy about exercise carries the same caveat honest copy about PRP does.

   Lawford BJ, Hall M, Hinman RS, et al. — Exercise for osteoarthritis of the knee. Cochrane Database of Systematic Reviews, 2024. DOI: 10.1002/14651858.CD004376.pub4.